bladdercancercarcinomacarecellclinicalcombinationcombinationsdrivingemergingevidencefirstfrontlinegenitourinaryguidelineimmunotherapyincorporationinhibitorlinemalignanciesmetastaticoptimizingpatientrecommendationsrecommendedrenalsecondstrategiestargetedtherapytreatmenturothelial